{"transactions":[{"id":992157,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-20T22:20:13.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":615,"price":9.27,"value":5701.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 58,866 RSUs."}],"balance_after":72646,"source":{"system":"sec-edgar","filing":"0001994972-25-000005","document":"form4-11202025_101109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000199497225000005/form4-11202025_101109.xml","form_type":"4"}},{"id":1016224,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:26:52.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":38,"price":9.561,"value":363.318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 60,546 RSUs.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":73261,"source":{"system":"sec-edgar","filing":"0001994972-25-000003","document":"form4-10172025_111047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000199497225000003/form4-10172025_111047.xml","form_type":"4"}},{"id":1016223,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:26:52.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":3344,"price":8.935,"value":29878.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":73299,"source":{"system":"sec-edgar","filing":"0001994972-25-000003","document":"form4-10172025_111047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000199497225000003/form4-10172025_111047.xml","form_type":"4"}},{"id":1016222,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:26:52.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":9570,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76643,"source":{"system":"sec-edgar","filing":"0001994972-25-000003","document":"form4-10172025_111047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000199497225000003/form4-10172025_111047.xml","form_type":"4"}},{"id":1059801,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":608,"price":4.668,"value":2838.144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,546 RSUs."}],"balance_after":67073,"source":{"system":"sec-edgar","filing":"0001415889-25-022475","document":"form4-08202025_090811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925022475/form4-08202025_090811.xml","form_type":"4"}},{"id":1139910,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:00:14.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":585,"price":2.774,"value":1622.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,226 RSUs."}],"balance_after":67681,"source":{"system":"sec-edgar","filing":"0001415889-25-013818","document":"form4-05202025_050506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925013818/form4-05202025_050506.xml","form_type":"4"}},{"id":1252064,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-21T22:09:13.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":2359,"price":4.413,"value":10410.267,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 63,906 RSUs."}],"balance_after":68266,"source":{"system":"sec-edgar","filing":"0001415889-25-005109","document":"form4-02212025_100209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925005109/form4-02212025_100209.xml","form_type":"4"}},{"id":1304797,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-10T21:55:04.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on January 7, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":87500,"derivative":{"exercise_price":7.33,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001415889-25-001283","document":"form4-01102025_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925001283/form4-01102025_040101.xml","form_type":"4"}},{"id":1304796,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-10T21:55:04.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are RSUs."}],"balance_after":70625,"source":{"system":"sec-edgar","filing":"0001415889-25-001283","document":"form4-01102025_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925001283/form4-01102025_040101.xml","form_type":"4"}},{"id":1656380,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-06T22:56:14.000Z","date":"2024-02-02","kind":"grant","planned":false,"acquired":true,"shares":161250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying the option vest and become exercisable on February 2, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":161250,"derivative":{"exercise_price":17,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":161250},"source":{"system":"sec-edgar","filing":"0001209191-24-002928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000120919124002928/doc4.xml","form_type":"4"}},{"id":1656379,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":72797,"kind":"person","name":"Adler Eric","position":1,"cik":"0001994972","reported_name":"Adler Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-06T22:56:14.000Z","date":"2024-02-02","kind":"grant","planned":false,"acquired":true,"shares":26875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":26875,"source":{"system":"sec-edgar","filing":"0001209191-24-002928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000120919124002928/doc4.xml","form_type":"4"}}]}